Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -7.08% is 76% above its 5-year average of -29.87%, near the high end of its 5-year range (-72.30%–11.00%).
As of the fiscal period ended Tuesday, June 30, 2026. 342.74% below its 12-month average of 2.92%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -7.08%.
RETURN ON INVESTED CAPITAL (ROIC)
-7.08%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
2.92%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-16.76%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-29.87%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-43.94%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-342.74%
CURRENT VS 3Y AVG
+57.76%
CURRENT VS 5Y AVG
+76.29%
CURRENT VS 10Y AVG
+83.89%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-28.79%
median of 492 covered companies
CURRENT VS SECTOR MEDIAN
+75.40%
vs the sector median at left
Akebia Therapeutics, Inc.
Market Cap
$241.70M
Return on Invested Capital (ROIC)
-7.08%
TTM Avg
2.92%
3Y Avg
-16.76%
5Y Avg
-29.87%
Market Cap
$244.19M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-8.11%
3Y Avg
-7.60%
5Y Avg
-6.24%
Market Cap
$246.96M
Return on Invested Capital (ROIC)
-1718.59%
TTM Avg
-749.70%
3Y Avg
-566.74%
5Y Avg
-409.31%
Market Cap
$251.06M
Return on Invested Capital (ROIC)
-59.90%
TTM Avg
-142.39%
3Y Avg
-118.24%
5Y Avg
-103.50%
Market Cap
$248.92M
Return on Invested Capital (ROIC)
-25.38%
TTM Avg
-99.58%
3Y Avg
-69.59%
5Y Avg
-61.10%
Market Cap
$249.82M
Return on Invested Capital (ROIC)
-701.55%
TTM Avg
-3723.51%
3Y Avg
-1911.77%
5Y Avg
-1278.48%
Market Cap
$240.76M
Return on Invested Capital (ROIC)
1.38%
TTM Avg
-1.85%
3Y Avg
-13.83%
5Y Avg
-10.66%
Market Cap
$242.46M
Return on Invested Capital (ROIC)
-28.14%
TTM Avg
-28.34%
3Y Avg
-154.06%
5Y Avg
-154.06%
Market Cap
$252.90M
Return on Invested Capital (ROIC)
-69.76%
TTM Avg
-64.00%
3Y Avg
-45.05%
5Y Avg
-31.07%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Akebia Therapeutics, Inc. (AKBA) | $241.70M | -7.08% | 2.92% | -16.76% | -29.87% |
| Lifecore Biomedical, Inc. (LFCR)vs › | $244.19M | N/A | -8.11% | -7.60% | -6.24% |
| Galectin Therapeutics Inc. (GALT)vs › | $246.96M | -1718.59% | -749.70% | -566.74% | -409.31% |
| Invivyd, Inc. (IVVD)vs › | $251.06M | -59.90% | -142.39% | -118.24% | -103.50% |
| InflaRx N.V. (IFRX)vs › | $248.92M | -25.38% | -99.58% | -69.59% | -61.10% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $249.82M | -701.55% | -3723.51% | -1911.77% | -1278.48% |
| High Tide Inc. (HITI)vs › | $240.76M | 1.38% | -1.85% | -13.83% | -10.66% |
| BioAge Labs Inc. (BIOA)vs › | $242.46M | -28.14% | -28.34% | -154.06% | -154.06% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $252.90M | -69.76% | -64.00% | -45.05% | -31.07% |
| Biodesix, Inc. (BDSX)vs › | $238.51M | -25.73% | -40.62% | -54.07% | -54.31% |
ROIC
-7.1%
ROE
-118.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -7.08% |
| 2026-03-31 | 2.63% |
| 2025-12-31 | 11.00% |
| 2025-09-30 | 7.69% |
| 2025-06-30 | 0.35% |
| 2025-03-31 | -10.06% |
| 2024-12-31 | -35.03% |
| 2024-09-30 | -24.22% |
| 2024-06-30 | -30.74% |
| 2024-03-31 | -22.39% |
| 2023-12-31 | -29.03% |
| 2023-09-30 | -33.06% |
| 2023-06-30 | -48.01% |
| 2023-03-31 | -22.15% |
| 2022-12-31 | -31.40% |
| 2022-09-30 | -44.66% |
| 2022-06-30 | -37.44% |
| 2022-03-31 | -68.04% |
| 2021-12-31 | -72.30% |
| 2021-09-30 | -68.89% |
| 2021-06-30 | -64.48% |
| 2021-03-31 | -83.82% |
| 2020-12-31 | -81.43% |
| 2020-09-30 | -78.02% |
| 2020-06-30 | -69.85% |
| 2020-03-31 | -46.56% |
| 2019-12-31 | -50.40% |
| 2019-09-30 | -49.21% |
| 2019-06-30 | -39.73% |
| 2019-03-31 | -33.36% |
| 2018-12-31 | -23.88% |
| 2018-09-30 | -33.85% |
| 2018-06-30 | -29.26% |
| 2018-03-31 | -20.41% |
| 2017-12-31 | -36.34% |
| 2017-09-30 | -69.07% |
| 2017-06-30 | -91.05% |
| 2017-03-31 | -123.53% |
| 2016-12-31 | -73.39% |
| 2016-09-30 | -82.86% |
| 2016-06-30 | -58.36% |
| 2016-03-31 | -36.85% |
| 2015-12-31 | -46.93% |
| 2015-09-30 | -35.81% |
| 2015-06-30 | -28.03% |
| 2015-03-31 | -41.14% |
| 2014-12-31 | -36.44% |
| 2014-09-30 | -29.51% |
| 2014-06-30 | -23.02% |
| 2014-03-31 | -18.19% |
| 2013-12-31 | -51.79% |
| 2013-09-30 | -32.60% |
